Status:
ENROLLING_BY_INVITATION
OpenEvidence Safety and Comparative Efficacy of Four LLM's in Clinical Practice
Lead Sponsor:
Cambridge Health Alliance
Conditions:
AI (Artificial Intelligence)
Large Language Model
Eligibility:
All Genders
Brief Summary
OpenEvidence is an online tool that aggregates and synthesizes data from peer-reviewed medical studies, then producing a response to a user's questions using generative AI. While it is in use by a num...
Detailed Description
OpenEvidence is an online tool built out of the May Clinic Platform Accelerate \[OpenEvidence\] that aggregates and synthesizes data from peer-reviewed medical studies, then producing a response to a ...
Eligibility Criteria
Inclusion
- Active trainees PGY-1 through PGY-6 in Internal Medicine, Family Medicine, Adult Psychiatry, or Child Psychiatry at Cambridge Health Alliance
- Must agree to the study protocol requirements outlined in the study description.
Exclusion
- Anyone who does not meet inclusion criteria
- Residents who plan to leave CHA prior to the end of the study collection period.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07199231
Start Date
October 1 2025
End Date
September 1 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Health Alliance
Cambridge, Massachusetts, United States, 02193